Physician profile
Elvis Torres
NPI 1225146491
$2,522.73
in general payments reported to CMS, 2019-2025
28 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $156 · 2021: $435 · 2022: $240 · 2023: $442 · 2024: $411 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.28 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $332.23 | 2021-2024 | |
| Exeltis, USA INC. | $263.83 | 2019-2025 | Slynd |
| Avion Pharmaceuticals | $145.20 | 2019-2023 | Balcoltra |
| Evofem Biosciences, INC. | $96.70 | 2021-2024 | |
| Astellas Pharma US INC | $92.19 | 2022-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $81.03 | 2019-2021 | |
| Medtronic, INC. | $75.95 | 2023 | V-Loc 180 |
| Ethicon US, LLC | $65.02 | 2019-2025 | Harmonic |
| Shield Therapeutics INC | $62.23 | 2022-2024 | Accrufer |
| Pfizer INC. | $56.79 | 2023-2024 | |
| Baxter Healthcare | $49.04 | 2025 | Perclot |
| Myovant Sciences INC. | $42.19 | 2021-2022 | |
| Sage Therapeutics, LLC | $39.81 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $36.69 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $36.28 | 2019-2023 | Citranatal |
| Coopersurgical, INC. | $32.29 | 2021 | |
| Mylan Pharmaceuticals INC. | $31.74 | 2020 | |
| Smith+Nephew, INC. | $30.58 | 2024 | Pico 7 |
| Exact Sciences Corporation | $24.54 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $20.40 | 2023 | Myfembree |
| Vertical Pharmaceuticals, LLC | $20.15 | 2019 | |
| Therapeuticsmd, INC. | $19.98 | 2022 | |
| Optumhealth Care Solutions, LLC | $18.40 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Scynexis, INC. | $15.97 | 2022 | |
| Roche Diagnostics Corporation | $14.94 | 2019 | |
| Organon LLC | $11.28 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elvis Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.